Compare, Analyse SHASUN PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
SHASUN PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs94376-   
Low Rs46271-   
Sales per share (Unadj.) Rs214.2111.9-  
Earnings per share (Unadj.) Rs5.3-28.2-  
Cash flow per share (Unadj.) Rs15.8-23.4-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.387.9-  
Shares outstanding (eoy) m56.62168.78-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.32.9 11.3%   
Avg P/E ratio x13.1-11.5 -114.1%  
P/CF ratio (eoy) x4.4-13.9 -31.9%  
Price / Book Value ratio x1.33.7 35.5%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,95854,660 7.2%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,1643,431 63.1%   
Avg. sales/employee Rs ThNM4,400.6-  
Avg. wages/employee Rs ThNM799.1-  
Avg. net profit/employee Rs ThNM-1,108.8-  
INCOME DATA
Net Sales Rs m12,12718,892 64.2%  
Other income Rs m229132 173.4%   
Total revenues Rs m12,35619,024 65.0%   
Gross profit Rs m1,009-3,274 -30.8%  
Depreciation Rs m594815 72.8%   
Interest Rs m415512 81.1%   
Profit before tax Rs m230-4,469 -5.1%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73279 -26.0%   
Profit after tax Rs m302-4,760 -6.3%  
Gross profit margin %8.3-17.3 -48.0%  
Effective tax rate %-31.7-6.2 506.7%   
Net profit margin %2.5-25.2 -9.9%  
BALANCE SHEET DATA
Current assets Rs m6,88413,837 49.8%   
Current liabilities Rs m8,4567,785 108.6%   
Net working cap to sales %-13.032.0 -40.5%  
Current ratio x0.81.8 45.8%  
Inventory Days Days62111 55.6%  
Debtors Days Days108124 86.8%  
Net fixed assets Rs m4,9708,065 61.6%   
Share capital Rs m11388 129.2%   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,02014,828 20.4%   
Long term debt Rs m1,8175,211 34.9%   
Total assets Rs m13,34728,011 47.6%  
Interest coverage x1.6-7.7 -20.1%   
Debt to equity ratio x0.60.4 171.2%  
Sales to assets ratio x0.90.7 134.7%   
Return on assets %5.4-15.2 -35.4%  
Return on equity %10.0-32.1 -31.2%  
Return on capital %13.3-19.8 -67.3%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m3981,613 24.7%  
From Investments Rs m-1,635-495 330.2%  
From Financial Activity Rs m1,3094,729 27.7%  
Net Cashflow Rs m715,847 1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.19 Rs / ZAR

Compare SHASUN PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SHASUN PHARMA With: TORRENT PHARMA  NOVARTIS  IPCA LABS  STRIDES PHARMA SCIENCE  WOCKHARDT  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Revealing at 5pm Today: The Great Indian Wealth Project
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHASUN PHARMA

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS